Related Experiment Videos

Reply to S. Barni et Al and M. Sun et Al

Marc B Garnick¹

¹Beth Israel Deaconess Medical Center, Boston, MA mgarnick@bidmc.harvard.edu.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|October 1, 2014

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate Cancer.

European urology·2026

First-Line [177Lu]Lu-PSMA-617 Therapy Without ADT, Chemotherapy, or Local Therapy for Metastatic Hormone-Sensitive Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.

The Canadian journal of urology·2024

A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group.

Urology practice·2023

Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.

The Journal of urology·2023

The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy.

Urologic oncology·2017

See all related articles